• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颈部淋巴结清扫的淋巴结产量可预测头颈癌的抗肿瘤免疫反应。

Nodal Yield From Neck Dissection Predicts the Anti-Tumor Immune Response in Head and Neck Cancers.

作者信息

Chen Shuqing, Pyne Justin M, Liu Yulun, Abraham Youstina, Wen Zhuoyu, Palsgrove Doreen, Xiao Guanghua, Truelson John, Myers Larry, Tillman Brittny, Day Andrew, Gordin Eli, Stankova Lenka, Xie Yang, Sher David, Bishop Justin, Gao Jinming, Sumer Baran D

机构信息

Department of Otolaryngology-Head & Neck Surgery, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

Department of Bioinformatics, University of Texas Southwestern Medical Center, Dallas, Texas, USA.

出版信息

Head Neck. 2025 Apr;47(4):1199-1208. doi: 10.1002/hed.28006. Epub 2024 Dec 16.

DOI:10.1002/hed.28006
PMID:39681999
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11907675/
Abstract

BACKGROUND

Lymph node count (LNC) from neck dissection has been associated with undernutrition and survival in head and neck squamous cell carcinoma (HNSCC). As local components of the immune system, cervical lymph nodes may reflect anti-tumor immune status. This study investigates the relationship between decreased LNC, formation of tertiary lymphoid structures (TLS), and primary tumor infiltration by lymphocytes in undernourished patients.

METHODS

A matched-cohort study was conducted in a tertiary medical center, where neck dissection quality was standardized for a total of 384 subjects that were evaluated. Six head and neck cancer patients that underwent primary surgery including neck dissection with low LNC and BMI (low BMI < 23, low LNC ≤ 5.6 per neck level) were matched by stage, p16 status, and subsite to 16 patients with normal BMI and high LNC. Multiplexed immunohistochemistry was used to evaluate the tumor-infiltrating lymphocytes and the number and quality of TLS within primary tumors. Whole primary cancers underwent automated analysis and counting of leukocytes after multiplexed immunohistochemistry staining of tumor slides. A head and neck pathologist blindly scored the number and maturity of TLS. Descriptive statistics were used to analyze outcomes.

RESULTS

The patients with low BMI and low LNC had significantly fewer CD3 (p = 0.0136), CD8 (p = 0.0003), and CD20 (p = 0.0334) cells in their primary tumors compared to patients with normal BMI and LNC. The low BMI low LNC patients also had fewer mature TLS (0.83/tumor) in their primary cancers compared to patients with normal BMI and high LNC (5.4/tumor) and also had greater than fourfold lower mature TLS density (TLS per μm mean) (6.34 × 10 vs. 2.82 × 10), with significantly worsened survival relative to patients with low BMI and normal LNC and patients with normal BMI.

CONCLUSION

Low LNC predicts worsened survival only in low BMI HNSCC patients with non-HPV related tumors and in these patients is associated with markers of immunosuppression such as fewer tumor-infiltrating CD8+ T-cells, CD20+ cells, and fewer TLS in primary cancers compared to matched normal BMI patients with high LNC.

摘要

背景

颈部清扫术中的淋巴结计数(LNC)与头颈部鳞状细胞癌(HNSCC)的营养不良和生存率相关。作为免疫系统的局部组成部分,颈部淋巴结可能反映抗肿瘤免疫状态。本研究调查了营养不良患者中LNC降低、三级淋巴结构(TLS)形成与原发性肿瘤淋巴细胞浸润之间的关系。

方法

在一家三级医疗中心进行了一项匹配队列研究,对总共384名接受评估的受试者的颈部清扫质量进行了标准化。6名头颈部癌症患者接受了包括颈部清扫术在内的初次手术,其LNC和体重指数较低(低体重指数<23,低LNC≤每个颈部水平5.6),根据分期、p16状态和亚部位与16名体重指数正常且LNC高的患者进行匹配。采用多重免疫组织化学法评估原发性肿瘤内的肿瘤浸润淋巴细胞以及TLS的数量和质量。在对肿瘤切片进行多重免疫组织化学染色后,对整个原发性癌进行白细胞的自动分析和计数。一名头颈部病理学家对TLS的数量和成熟度进行盲法评分。采用描述性统计分析结果。

结果

与体重指数和LNC正常的患者相比,体重指数低且LNC低的患者原发性肿瘤中的CD3(p = 0.0136)、CD8(p = 0.0003)和CD20(p = 0.0334)细胞明显减少。与体重指数正常且LNC高的患者(5.4/肿瘤)相比,体重指数低且LNC低的患者原发性癌中的成熟TLS也较少(0.83/肿瘤),并且成熟TLS密度(每μm平均值的TLS)降低超过四倍(6.34×10对2.82×10),相对于体重指数低且LNC正常的患者以及体重指数正常的患者,其生存率显著恶化。

结论

低LNC仅在患有非HPV相关肿瘤的低体重指数HNSCC患者中预示生存率恶化,并且在这些患者中,与免疫抑制标志物相关,例如与匹配的体重指数正常且LNC高的患者相比,原发性癌中肿瘤浸润的CD8 + T细胞、CD20 +细胞较少,TLS也较少。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/aab17c667996/HED-47-1199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/63e4c087cf08/HED-47-1199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/8332368d88ec/HED-47-1199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/aab17c667996/HED-47-1199-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/63e4c087cf08/HED-47-1199-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/8332368d88ec/HED-47-1199-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3767/11907675/aab17c667996/HED-47-1199-g003.jpg

相似文献

1
Nodal Yield From Neck Dissection Predicts the Anti-Tumor Immune Response in Head and Neck Cancers.颈部淋巴结清扫的淋巴结产量可预测头颈癌的抗肿瘤免疫反应。
Head Neck. 2025 Apr;47(4):1199-1208. doi: 10.1002/hed.28006. Epub 2024 Dec 16.
2
Factors Associated with Lymph Node Count in Mucosal Squamous Cell Carcinoma Neck Dissection.黏膜鳞状细胞癌颈部解剖中淋巴结计数的相关因素。
Laryngoscope. 2021 Jul;131(7):1516-1521. doi: 10.1002/lary.29353. Epub 2021 Jan 4.
3
Distinct maturity and spatial distribution of tertiary lymphoid structures in head and neck squamous cell carcinoma: implications for tumor immunity and clinical outcomes.头颈部鳞状细胞癌中三级淋巴结构的不同成熟度和空间分布:对肿瘤免疫和临床结果的影响
Cancer Immunol Immunother. 2025 Feb 11;74(3):107. doi: 10.1007/s00262-025-03952-1.
4
Lymph node yield in treatment naïve cases of head and neck squamous cell carcinoma: en bloc lymphadenectomy versus level-by-level dissection.治疗初治头颈部鳞状细胞癌时的淋巴结产量:整块淋巴结切除术与逐层解剖术。
J Laryngol Otol. 2021 Apr;135(4):359-366. doi: 10.1017/S0022215121000621. Epub 2021 Mar 15.
5
Tertiary lymphoid structure-related score as a predictor for survival prognosis and immunotherapy response in head and neck squamous cell carcinoma.三阴性乳腺癌相关评分作为预测头颈部鳞状细胞癌生存预后和免疫治疗反应的指标。
Front Immunol. 2024 Oct 18;15:1483497. doi: 10.3389/fimmu.2024.1483497. eCollection 2024.
6
Prognostic and predictive values of immune infiltrate in patients with head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者免疫浸润的预后和预测价值。
Hum Pathol. 2018 Dec;82:104-112. doi: 10.1016/j.humpath.2018.07.012. Epub 2018 Jul 20.
7
Prognostic Role of Tumor-Infiltrating Lymphocytes and Tumor Budding in Early Oral Tongue Carcinoma.肿瘤浸润淋巴细胞和肿瘤芽殖在早期口腔舌癌中的预后作用
Laryngoscope. 2021 Nov;131(11):2512-2518. doi: 10.1002/lary.29589. Epub 2021 May 6.
8
Lymph Node Count From Neck Dissection Predicts Mortality in Head and Neck Cancer.颈部淋巴结清扫术的淋巴结计数可预测头颈部癌症的死亡率。
J Clin Oncol. 2016 Nov 10;34(32):3892-3897. doi: 10.1200/JCO.2016.67.3863.
9
A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma.肿瘤相关基质浸润淋巴细胞的数字评分可预测头颈部鳞状细胞癌的生存。
J Pathol. 2022 Feb;256(2):174-185. doi: 10.1002/path.5819. Epub 2021 Nov 24.
10
Minimum lymph node yield in elective level I-III neck dissection.I-III 区选择性颈部清扫术中的最小淋巴结收获量
Laryngoscope. 2017 Sep;127(9):2070-2073. doi: 10.1002/lary.26545. Epub 2017 Mar 8.

本文引用的文献

1
Tertiary lymphoid structural heterogeneity determines tumour immunity and prospects for clinical application.三级淋巴结构异质性决定肿瘤免疫和临床应用前景。
Mol Cancer. 2024 Apr 6;23(1):75. doi: 10.1186/s12943-024-01980-6.
2
The roles of tertiary lymphoid structures in chronic diseases.三级淋巴结构在慢性疾病中的作用。
Nat Rev Nephrol. 2023 Aug;19(8):525-537. doi: 10.1038/s41581-023-00706-z. Epub 2023 Apr 12.
3
Tertiary lymphoid structures in head and neck squamous cell carcinoma improve prognosis by recruiting CD8 T cells.
头颈部鳞状细胞癌中的三级淋巴结构通过募集 CD8 T 细胞改善预后。
Mol Oncol. 2023 Aug;17(8):1514-1530. doi: 10.1002/1878-0261.13403. Epub 2023 Mar 8.
4
Inhibitors of immune checkpoints-PD-1, PD-L1, CTLA-4-new opportunities for cancer patients and a new challenge for internists and general practitioners.免疫检查点抑制剂-PD-1、PD-L1、CTLA-4-为癌症患者带来新机遇,也为内科医生和全科医生带来新挑战。
Cancer Metastasis Rev. 2021 Sep;40(3):949-982. doi: 10.1007/s10555-021-09976-0. Epub 2021 Jul 8.
5
Factors Associated with Lymph Node Count in Mucosal Squamous Cell Carcinoma Neck Dissection.黏膜鳞状细胞癌颈部解剖中淋巴结计数的相关因素。
Laryngoscope. 2021 Jul;131(7):1516-1521. doi: 10.1002/lary.29353. Epub 2021 Jan 4.
6
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.肿瘤突变负荷作为免疫治疗生物标志物面临的挑战。
Cancer Cell. 2021 Feb 8;39(2):154-173. doi: 10.1016/j.ccell.2020.10.001. Epub 2020 Oct 29.
7
Pretreatment body mass index and clinical outcomes in cancer patients following immune checkpoint inhibitors: a systematic review and meta-analysis.免疫检查点抑制剂治疗后癌症患者的预处理体重指数与临床结局:系统评价和荟萃分析。
Cancer Immunol Immunother. 2020 Dec;69(12):2413-2424. doi: 10.1007/s00262-020-02680-y. Epub 2020 Aug 4.
8
B cells are associated with survival and immunotherapy response in sarcoma.B 细胞与肉瘤的生存和免疫治疗反应有关。
Nature. 2020 Jan;577(7791):556-560. doi: 10.1038/s41586-019-1906-8. Epub 2020 Jan 15.
9
B cells and tertiary lymphoid structures promote immunotherapy response.B 细胞和三级淋巴结构促进免疫治疗反应。
Nature. 2020 Jan;577(7791):549-555. doi: 10.1038/s41586-019-1922-8. Epub 2020 Jan 15.
10
Tertiary lymphoid structures improve immunotherapy and survival in melanoma.三级淋巴结构可改善黑色素瘤的免疫治疗和生存率。
Nature. 2020 Jan;577(7791):561-565. doi: 10.1038/s41586-019-1914-8. Epub 2020 Jan 15.